Immunosuppressive Drugs and COVID-19: A Review

BACKGROUND: Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It is currently unknown whether immunosuppressive drugs are advantageous or detrimental in patients with COVID-19. Immunosuppressive drugs could be harmful in the initial phase...

Descripción completa

Detalles Bibliográficos
Autores principales: Schoot, Tessa S., Kerckhoffs, Angèle P. M., Hilbrands, Luuk B., van Marum, Rob J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7485413/
https://www.ncbi.nlm.nih.gov/pubmed/32982743
http://dx.doi.org/10.3389/fphar.2020.01333

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7485413/
https://www.ncbi.nlm.nih.gov/pubmed/32982743
http://dx.doi.org/10.3389/fphar.2020.01333

Ejemplares similares